{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:04:16Z","timestamp":1790240656969,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T00:00:00Z","timestamp":1715731200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005198","name":"China Foundation for Hepatitis Prevention and Control","doi-asserted-by":"publisher","award":["TQGB20210068"],"award-info":[{"award-number":["TQGB20210068"]}],"id":[{"id":"10.13039\/501100005198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e31412","type":"journal-article","created":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T13:20:21Z","timestamp":1715952021000},"page":"e31412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0252-3097","authenticated-orcid":false,"given":"Yaming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maochuan","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiusong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.heliyon.2024.e31412_bib1","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3350\/cmh.2023.0106","article-title":"Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences","volume":"29","author":"Yang","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e31412_bib2","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/apt.15575","article-title":"Systematic review: chronic viral hepatitis and metabolic derangement","volume":"51","author":"Wang","year":"2020","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31412_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12072-018-9903-9","article-title":"Fatty liver checkmates hepatitis B virus","volume":"12","author":"Ramakrishna","year":"2018","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31412_bib4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cld.2019.05.001","article-title":"The effects of hepatic steatosis on the natural history of HBV infection","volume":"23","author":"Suliman","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.heliyon.2024.e31412_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41577-021-00549-4","article-title":"Immunobiology and pathogenesis of hepatitis B virus infection","author":"Iannacone","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.heliyon.2024.e31412_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1051280","article-title":"Apolipoproteins: new players in cancers","volume":"13","author":"He","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e31412_bib7","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/jmv.23961","article-title":"High expression of beta2-glycoprotein I is associated significantly with the earliest stages of hepatitis B virus infection","volume":"86","author":"Liu","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.heliyon.2024.e31412_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105906","article-title":"Apolipoprotein H drives hepatitis B surface antigen retention and endoplasmic reticulum stress during hepatitis B virus infection","volume":"131","author":"Liu","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31412_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12944-022-01699-7","article-title":"Alcohol-dependent downregulation of apolipoprotein H exacerbates fatty liver and gut microbiota dysbiosis in mice","volume":"21","author":"Liu","year":"2022","journal-title":"Lipids Health Dis."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e31412_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106100","article-title":"Apolipoprotein H induces sex-specific steatohepatitis and gut dysbiosis during chronic hepatitis B infection","volume":"26","author":"Liu","year":"2023","journal-title":"iScience"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31412_bib11","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31412_bib12","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31412_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","article-title":"xCell: digitally portraying the tissue cellular heterogeneity landscape","volume":"18","author":"Aran","year":"2017","journal-title":"Genome Biol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31412_bib14","doi-asserted-by":"crossref","first-page":"452","DOI":"10.21037\/hbsn-20-480","article-title":"2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights","volume":"9","author":"Xie","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.heliyon.2024.e31412_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejrad.2018.01.025","article-title":"Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines","volume":"101","author":"Ayuso","year":"2018","journal-title":"Eur. J. Radiol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e31412_bib16","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31412_bib17","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee, European association for the study of the L: EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e31412_bib18","article-title":"Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes","author":"Lee","year":"2022","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e31412_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu11112588","article-title":"Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review","volume":"11","author":"Chambers","year":"2019","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.heliyon.2024.e31412_bib20","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/hep.32740","article-title":"The liver cancer immune microenvironment: therapeutic implications for hepatocellular carcinoma","volume":"77","author":"Donne","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e31412_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5115\/acb.21.046","article-title":"Role of macrophages in liver cirrhosis: fibrogenesis and resolution","volume":"55","author":"Elsherif","year":"2022","journal-title":"Anat Cell Biol"},{"key":"10.1016\/j.heliyon.2024.e31412_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.imlet.2017.03.013","article-title":"beta2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome","volume":"186","author":"Bai","year":"2017","journal-title":"Immunol. Lett."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024074437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024074437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:24:42Z","timestamp":1790238282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024074437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024074437"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31412","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein H-based prognostic risk correlates with liver lipid metabolism disorder in patients with HBV-related hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e31412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e31412"}}